Frontier Group Holdings Inc. (NASDAQ:ULCC) reported its fourth-quarter 2024 earnings, showcasing a significant earnings per share (EPS) beat with actual EPS of $0.23 compared to the forecasted $0.04.
Acelia Pharma reported its Q4 2024 earnings, focusing on its strategic advancements and financial stability. The company announced an operating loss of 21.9 million kronor, while maintaining a cash ...
Some results have been hidden because they may be inaccessible to you